Pfizer, the leading global health company reiterated its commitment to fighting counterfeit medicines by helping to build capacity of major stakeholders in the health sector including decision makers, by partnering with the Government of Ethiopia's regulatory agencies and through creating awareness by the use of media.
Pfizer also announced that it will launch products in its Cardio Vascular (CV) portfolio in response to the rising incidence of cardiovascular diseases in the country.
In his speech during a press briefing at the Hilton hotel on April 24, Dr. Enrico Liggeri, Country Manager, Nigeria and East Africa region (NEAR) described Ethiopia as the second largest market interest and focus of business expansion.
As part of its awareness campaign, Pfizer partnered with the AU to engage medical experts and created a platform to discuss current trends on cardiovascular diseases in the country.